Inactive Instrument

Other languages Pressure BioSciences, Inc. Nasdaq

Equities

US74112E1091

End-of-day quote Nasdaq Other stock markets
- ^USD	-

06-25	Pressure BioSciences, Inc. Partners with Vita-Forte to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray	CI
06-20	Transcript : Pressure BioSciences, Inc. - Special Call

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Pressure BioSciences, Inc. Partners with Vita-Forte to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray	06-25
Pressure BioSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06-07
Pressure BioSciences, Inc. Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing	02-15
Pressure BioSciences, Inc. completed the acquisition of CBH International LLC.	01-21
Pressure BioSciences, Inc. Receives Open Order Agreement from West Coast Manufacturing Partner	01-18
Pressure BioSciences' BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies	01-04
Pressure BioSciences, Inc. Announces the Publication of Pivotal Scientific Study in the Critical Field of Food Safety	12-12
Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador	12-01
Pressure BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-20
Pressure Biosciences Announces Exclusive Distribution Agreement with Bioscreen Instruments Pvt Ltd	18/10/23
Pressure BioSciences' Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effective Immediately	22/09/23
Pressure BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21/08/23
Pressure BioSciences, Inc. Announces UltraShear Nano-CBD Roll-Out Program Enters Rapid Expansion Phase of Distribution and Partnering	17/07/23
Pressure BioSciences, Inc. Announces UltraShear Processed Nano-CBD Topical Spray Distribution Agreement with Premier CA Cannabis Partner Creme de Canna	10/07/23
Pressure BioSciences, Inc. Announces Agreement with Somalab International LLC for Development & Distribution of UltraShear-Enabled Nanoemulsified Health and Wellness Products	05/07/23
Pressure Biosciences, Inc. Announces Results from Third Round of Consumer Focus Group Testing of THC Nanoemulsion Oral Spray	27/06/23
Pressure BioSciences, Inc. Partners with Veterans Service Team to Offer Exclusive Access for VST Members to a Unique, Custom-Made, UltraShear Nano-CBD & Other Products	13/06/23
Pressure BioSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Pressure BioSciences Unveils Powerful THC Market Leapfrog Opportunity with Exclusive Licensing of Their Revolutionary UltraShear Nanoemulsion Processing Platform	21/04/23
Pressure BioSciences, Inc. Provides Earnings Guidance for the First Quarter of 2023	13/04/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Pressure BioSciences, Inc. Nasdaq

Equities

US74112E1091

Other languages

Filters